KALA - Kala Bio Inc.
Previous close
5.89
0 0%
Share volume: 1,560
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$5.89
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | |
| Report Date | 2022-05-16 | 2022-08-11 | 2022-11-08 | 2023-03-03 | 2023-05-09 | 2023-08-04 | |
| Assets | |||||||
| Total Assets | 111.574 M | 84.976 M | 85.698 M | 86.820 M | 72.226 M | 66.500 M | |
| Current Assets | 98.255 M | 83.515 M | 84.672 M | 85.942 M | 71.344 M | 65.535 M | |
| Inventories | 10.531 M | 25.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 4.542 M | 2.143 M | 22.576 M | 7.657 M | 2.353 M | 1.113 M | |
| Short Term Investments | 4.542 M | 2.143 M | 22.576 M | 7.657 M | 2.353 M | 1.113 M | |
| Total Receivables | 13.020 M | 13.822 M | 190.000 K | 195.000 K | 0.000 | 0.000 | |
| Current Cash | 70.162 M | 44.568 M | 52.393 M | 70.495 M | 63.636 M | 59.178 M | |
| Total Non-current Assets | 13.319 M | 1.461 M | 1.026 M | 878.000 K | 882.000 K | 965.000 K | |
| Property Plant Equipment | 2.704 M | 891.000 K | 517.000 K | 400.000 K | 504.000 K | 637.000 K | |
| Other Assets | 9.186 M | 51.000 K | 34.000 K | 16.000 K | 6.000 K | 0.000 | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 111.574 M | 84.976 M | 85.698 M | 86.820 M | 72.226 M | 66.500 M | |
| Total liabilities | 116.858 M | 116.530 M | 86.666 M | 67.846 M | 48.765 M | 49.008 M | |
| Total current liabilities | 32.758 M | 32.891 M | 40.241 M | 25.685 M | 10.265 M | 9.851 M | |
| Accounts Payable | 6.218 M | 10.542 M | 7.348 M | 2.832 M | 997.000 K | 760.000 K | |
| Other liabilities | 4.002 M | 3.839 M | 3.783 M | 4.224 M | 5.234 M | 5.588 M | |
| Current long term debt | 625.000 K | 52.000 K | 32.000 K | 5.013 M | 3.000 K | 0.000 | |
| Long term debt | 80.098 M | 79.800 M | 42.642 M | 37.937 M | 33.266 M | 33.569 M | |
| Other liabilities | 4.002 M | 3.839 M | 3.783 M | 4.224 M | 5.234 M | 5.588 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -5.284 M | -31.554 M | -968.000 K | 18.974 M | 23.461 M | 17.492 M | |
| Common stock | 1.473 M | 1.474 M | 1.499 M | 1.637 M | 2.069 M | 2.388 M | |
| Retained earnings | -575.329 M | -603.440 M | -574.367 M | -587.210 M | -601.665 M | -612.078 M |